Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients

Cell

Volumn 165, Issue 3, 2016, Pages 551-565

  Banchereau, Romain ^a   Hong, Seunghee ^a   Cantarel, Brandi ^a   Baldwin, Nicole ^a   Baisch, Jeanine ^a   Edens, Michelle ^a   Cepika, Alma Martina ^a   Acs, Peter ^a   Turner, Jacob ^a   Anguiano, Esperanza ^a   Vinod, Parvathi ^a   Kahn, Shaheen ^b   Obermoser, Gerlinde ^a   Blankenship, Derek ^a   Wakeland, Edward ^b   Nassi, Lorien ^b,c   Gotte, Alisa ^b,c,d   Punaro, Marilynn ^b,c   Liu, Yong Jun ^a,e   Banchereau, Jacques ^f   Rossello Urgell, Jose ^a   Wright, Tracey ^b,c   Pascual, Virginia ^a,c   more..

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MEDIMMUNE   (United States)

^f JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; INTERFERON; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; STEROID; TRANSCRIPTOME;

ACCURACY; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; GENETIC HETEROGENEITY; HUMAN; IMMUNOLOGICAL MONITORING; LONGITUDINAL STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MOLECULAR HETEROGENEITY; MOLECULAR PATHOLOGY; NEUTROPHIL; PERSONALIZED MEDICINE; PLASMABLAST; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTOMICS; ADOLESCENT; CHILD; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PATHOLOGY;

ADOLESCENT; CHILD; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; NEUTROPHILS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECISION MEDICINE; TRANSCRIPTOME;

EID: 84962128086     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.03.008     Document Type: Article

References (35)

1. M.R. Arbuckle, M.T. McClain, M.V. Rubertone, R.H. Scofield, G.J. Dennis, J.A. James, and J.B. Harley Development of autoantibodies before the clinical onset of systemic lupus erythematosus N. Engl. J. Med. 349 2003 1526 1533
2. E.C. Baechler, F.M. Batliwalla, G. Karypis, P.M. Gaffney, W.A. Ortmann, K.J. Espe, K.B. Shark, W.J. Grande, K.M. Hughes, V. Kapur, and et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus Proc. Natl. Acad. Sci. USA 100 2003 2610 2615
3. L. Bennett, A.K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual Interferon and granulopoiesis signatures in systemic lupus erythematosus blood J. Exp. Med. 197 2003 711 723
4. J. Bentham, D.L. Morris, D.S. Cunninghame Graham, C.L. Pinder, P. Tombleson, T.W. Behrens, J. Martín, B.P. Fairfax, J.C. Knight, L. Chen, and et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus Nat. Genet. 47 2015 1457 1464
5. S. Bernatsky, J.F. Boivin, L. Joseph, S. Manzi, E. Ginzler, D.D. Gladman, M. Urowitz, P.R. Fortin, M. Petri, S. Barr, and et al. Mortality in systemic lupus erythematosus Arthritis Rheum. 54 2006 2550 2557
6. M.P. Berry, C.M. Graham, F.W. McNab, Z. Xu, S.A. Bloch, T. Oni, K.A. Wilkinson, R. Banchereau, J. Skinner, R.J. Wilkinson, and et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis Nature 466 2010 973 977
7. C. Bombardier, D.D. Gladman, M.B. Urowitz, D. Caron, C.H. Chang The Committee on Prognosis Studies in SLE Derivation of the SLEDAI. A disease activity index for lupus patients Arthritis Rheum. 35 1992 630 640
8. D. Chaussabel, and N. Baldwin Democratizing systems immunology with modular transcriptional repertoire analyses Nat. Rev. Immunol. 14 2014 271 280
9. D. Chaussabel, C. Quinn, J. Shen, P. Patel, C. Glaser, N. Baldwin, D. Stichweh, D. Blankenship, L. Li, I. Munagala, and et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus Immunity 29 2008 150 164
10. M.H. Cheng, and M.S. Anderson Monogenic autoimmunity Annu. Rev. Immunol. 30 2012 393 427
11. L. Chiche, N. Jourde-Chiche, E. Whalen, S. Presnell, V. Gersuk, K. Dang, E. Anguiano, C. Quinn, S. Burtey, Y. Berland, and et al. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures Arthritis Rheumatol. 66 2014 1583 1595
12. G.S. Garcia-Romo, S. Caielli, B. Vega, J. Connolly, F. Allantaz, Z. Xu, M. Punaro, J. Baisch, C. Guiducci, R.L. Coffman, and et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus Sci. Transl. Med. 3 2011 73ra20
13. A. Hakkim, B.G. Fürnrohr, K. Amann, B. Laube, U.A. Abed, V. Brinkmann, M. Herrmann, R.E. Voll, and A. Zychlinsky Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis Proc. Natl. Acad. Sci. USA 107 2010 9813 9818
14. C.A. Jonsson, and H. Carlsten Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells Int. Immunopharmacol. 3 2003 31 37
15. K.A. Kirou, C. Lee, S. George, K. Louca, M.G. Peterson, and M.K. Crow Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease Arthritis Rheum. 52 2005 1491 1503
16. S.M. Korbet, M.M. Schwartz, J. Evans, E.J. Lewis Collaborative Study Group Severe lupus nephritis: racial differences in presentation and outcome J. Am. Soc. Nephrol. 18 2007 244 254
17. P. Langfelder, and S. Horvath WGCNA: an R package for weighted correlation network analysis BMC Bioinformatics 9 2008 559
18. E.F. McKinney, J.C. Lee, D.R. Jayne, P.A. Lyons, and K.G. Smith T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection Nature 523 2015 612 616
19. J.T. Merrill, C.M. Neuwelt, D.J. Wallace, J.C. Shanahan, K.M. Latinis, J.C. Oates, T.O. Utset, C. Gordon, D.A. Isenberg, H.J. Hsieh, and et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial Arthritis Rheum. 62 2010 222 233
20. S.V. Navarra, R.M. Guzmán, A.E. Gallacher, S. Hall, R.A. Levy, R.E. Jimenez, E.K. Li, M. Thomas, H.Y. Kim, M.G. León, et al. BLISS-52 Study Group Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial Lancet 377 2011 721 731
21. N. Novershtern, A. Subramanian, L.N. Lawton, R.H. Mak, W.N. Haining, M.E. McConkey, N. Habib, N. Yosef, C.Y. Chang, T. Shay, and et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis Cell 144 2011 296 309
22. M. Odendahl, A. Jacobi, A. Hansen, E. Feist, F. Hiepe, G.R. Burmester, P.E. Lipsky, A. Radbruch, and T. Dörner Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus J. Immunol. 165 2000 5970 5979
23. M. Petri, S. Singh, H. Tesfasyone, R. Dedrick, K. Fry, P. Lal, G. Williams, J. Bauer, P. Gregersen, T. Behrens, and E. Baechler Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus Lupus 18 2009 980 989
24. L.L. Ritterhouse, S.R. Crowe, T.B. Niewold, J.T. Merrill, V.C. Roberts, A.B. Dedeke, B.R. Neas, L.F. Thompson, J.M. Guthridge, and J.A. James B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels Arthritis Rheum. 63 2011 3931 3941
25. I. Rusinova, S. Forster, S. Yu, A. Kannan, M. Masse, H. Cumming, R. Chapman, and P.J. Hertzog Interferome v2.0: an updated database of annotated interferon-regulated genes Nucleic Acids Res. 41 2013 D1040 D1046
26. I. Sanz, and F.E. Lee B cells as therapeutic targets in SLE Nat. Rev. Rheumatol. 6 2010 326 337
27. P. Shannon, A. Markiel, O. Ozier, N.S. Baliga, J.T. Wang, D. Ramage, N. Amin, B. Schwikowski, and T. Ideker Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Res. 13 2003 2498 2504
28. K. Streicher, C.A. Morehouse, C.J. Groves, B. Rajan, F. Pilataxi, K.P. Lehmann, P.Z. Brohawn, B.W. Higgs, K. McKeever, S.A. Greenberg, and et al. The plasma cell signature in autoimmune disease Arthritis Rheumatol. 66 2014 173 184
29. G.C. Tsokos Systemic lupus erythematosus N. Engl. J. Med. 365 2011 2110 2121
30. J.A. Turner, C.R. Bolen, and D.M. Blankenship Quantitative gene set analysis generalized for repeated measures, confounder adjustment, and continuous covariates BMC Bioinformatics 16 2015 272
31. M.F. Ugarte-Gil, and G.S. Alarcón Systemic lupus erythematosus: a therapeutic challenge for the XXI century Clin. Rheumatol. 33 2014 441 450
32. E. Villanueva, S. Yalavarthi, C.C. Berthier, J.B. Hodgin, R. Khandpur, A.M. Lin, C.J. Rubin, W. Zhao, S.H. Olsen, M. Klinker, and et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus J. Immunol. 187 2011 538 552
33. J.J. Weening, V.D. D'Agati, M.M. Schwartz, S.V. Seshan, C.E. Alpers, G.B. Appel, J.E. Balow, J.A. Bruijn, T. Cook, F. Ferrario, and et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited J. Am. Soc. Nephrol. 15 2004 241 250
34. G. Yaari, C.R. Bolen, J. Thakar, and S.H. Kleinstein Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations Nucleic Acids Res. 41 2013 e170
35. B. Zhang, and S. Horvath A general framework for weighted gene co-expression network analysis Stat. Appl. Genet. Mol. Biol. 4 2005 Article17